
Quest PharmaTech Inc has seen a notable uptick in its stock price this week, reflecting a 20% increase.
Quest PharmaTech Inc (QPT.V) has experienced significant price movement, gaining 20% over the past week. This uptick is notable given the lack of major news or announcements from the company. Investors may be keen to understand the technical picture behind this recent performance.
Advertisement
Quest PharmaTech Inc
QPT.V
QPT.V
Quest PharmaTech Inc
Market cap
$4.23M
P/E
0.8x
52W high
$0.05
52W low
$0.02
1W change
+20.00%
Beta
-0.31
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on QPT's historical volatility
30-Day Vol
233.9%
Annualized
90-Day Vol
214.6%
Annualized
Trend (90d)
-0.0%
Annualized drift
90d Mean
C$0.03
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.03 | C$0.01 – C$0.07 |
| 60 trading days | C$0.03 | C$0.01 – C$0.09 |
| 90 trading days | C$0.03 | C$0.01 – C$0.12 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: While Quest PharmaTech's stock has risen sharply in the short term, investors should consider the context of its technical indicators and overall market conditions before making decisions.
Quest PharmaTech Inc's stock up 20% this week.
Despite the recent gains, the stock's performance has been volatile, with a 52-week range from C$0.02 to C$0.05.
Bull case
The recent price surge suggests that investors are becoming more interested in Quest PharmaTech, possibly reflecting optimism about the company's future, especially in the health care sector.
Bear case
Despite the recent gains, the stock is still down year-to-date, and the low trading volume compared to its average indicates that investors are cautious.
Recent Price Action
This week, Quest PharmaTech Inc (QPT.V) has shown strong performance, closing at C$0.03, marking a 20% increase in just one day and a cumulative 20% rise over the week. This performance is notable as it comes amid a year-to-date decline of 14.29%. Over the past month, the stock has gained an impressive 50%, indicating a potential recovery phase.
Advertisement
Technical Picture
Analyzing the technical indicators for Quest PharmaTech, the stock is currently trading at C$0.03, which is above its 50-day moving average of C$0.02 by 27.1%. However, it is slightly below the 200-day moving average of C$0.03, showing a decline of 7.4% compared to the price. The stock's 52-week range stands at C$0.02 to C$0.05, meaning it is currently at 33% of its range. The beta of -0.31 suggests that the stock is less volatile than the broader market, which may appeal to more conservative investors. Notably, the trading volume has been lower than the 20-day average, with the latest volume at 16,000 shares compared to an average of 35,667 shares.
Insider Activity
There has been no recent insider activity reported for Quest PharmaTech Inc, which can sometimes indicate management's confidence in the company's future prospects.
Conclusion
In conclusion, Quest PharmaTech Inc (QPT.V) has demonstrated substantial price movement this week, with a last close of C$0.03, reflecting a 20% increase. Investors should consider both the recent gains and the technical indicators before making any investment decisions.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


